Aktiia, now rebranded as Hilo, has successfully raised $42 million in an oversubscribed Series B funding round to enhance its cuffless blood pressure monitoring solutions and expand its market presence.

Information on the Target

Aktiia, now rebranded as Hilo, is a pioneering blood pressure intelligence platform established in 2018. The company focuses on revolutionizing how blood pressure is measured and managed through innovative technology. With an extensive portfolio, Hilo has successfully sold over 120,000 devices, leveraging advanced AI algorithms integrated with vast datasets to provide convenient and insightful reports. This robust approach helps both individuals and healthcare professionals effectively monitor blood pressure.

The recent funding signifies a vital step in Hilo's journey, as they aim to enhance accessibility to cuffless, clinically validated blood pressure monitoring solutions globally. The company’s foundational Machine Learning model for blood pressure monitoring has been trained on billions of optical signals and refined through hundreds of millions of calibration points, establishing Hilo as a leader in the emerging cuffless blood pressure monitoring (CBPM) sector.

Industry Overview in Switzerland

Switzerland is recognized for its strong healthcare system, characterized by high standards of medical services and innovative health technologies. The country invests heavily in research and development, contributing to a